Cargando…
Treatment of drug-induced immune thrombocytopenias
Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated mechanisms. Non-immune-mediated thrombocytopenia is due to direct toxicity of drug molecules to platelets or megakaryocytes. Immune-mediated thrombocytopenia, on the other hand, involves the format...
Autores principales: | Marini, Irene, Uzun, Gunalp, Jamal, Kinan, Bakchoul, Tamam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152960/ https://www.ncbi.nlm.nih.gov/pubmed/35642486 http://dx.doi.org/10.3324/haematol.2021.279484 |
Ejemplares similares
-
Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
por: Singh, Anurag, et al.
Publicado: (2021) -
Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2022) -
Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia
por: Hirsch, Johannes, et al.
Publicado: (2023) -
Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
por: Zlamal, Jan, et al.
Publicado: (2023) -
No Correlation between Anti-PF4 and Anti–SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination
por: Uzun, Günalp, et al.
Publicado: (2021)